日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Vaccine scandal probes continue, punishments promised

By Yang Wanli | China Daily | Updated: 2018-08-16 09:16
Share
Share - WeChat
[Photo/VCG]

Investigations into substandard vaccines at Changchun Changsheng Bio-tech Co are continuing after the State Council vowed severe punishment would be given to those responsible for the recent scandal.

An investigative team sent by the State Council said on Wednesday that it found the company produced two batches of substandard diphtheria, tetanus and whooping cough (DTaP) vaccine - 499,800 doses - according to Xinhua News Agency.

Doses from one batch of 252,600 were all sold in Shandong province. Of those, 247,359 had been used and 5,241 were sealed for safekeeping.

Another 247,200 doses from another batch were sold in Shandong and Anhui provinces. Of those, more than 10,000 were sealed by the health department in Shandong and 3,277 were sealed in Anhui.

The team didn't say whether or not the remaining unsealed doses had been used.

"The investigation will continue, and severe punishment will be given to anyone involved," the team said.

Moreover, it said, local governments and private parties that neglected their duty will be punished, promising to announce the investigation results in a timely manner.

Nearly 77 percent of children who had taken the first batch of substandard DTaP vaccine have been revaccinated since February, the statement said.

The National Health Commission and the State Drug Administration jointly came up with a revaccination plan for the children who had taken the substandard vaccines. Details have not yet been released.

The statement said that other than the two problem batches, DTaP vaccines from Changsheng were found to be safe.

Along with Changchun Changsheng Bio-tech Co, Wuhan Institute of Biological Products Co in Hubei province was reported to have produced substandard DTaP vaccines last year.

A total of 400,520 doses of substandard vaccine produced by the company were sold to Hebei province and Chongqing municipality.

Changchun Changsheng stopped production of DTaP vaccine last year, according to the State Drug Administration.

The Wuhan company has resumed production after having 30 batches of DTaP vaccine successfully pass testing by the National Institutes for Food and Drug Control.

According to the China Center for Disease Control and Prevention, the substandard DTaP vaccines will not harm the body, but they won't provide good immunity.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 国产 高清 在线 | 久久午夜精品 | 午夜第一页 | 国产成人精品三级 | 狠狠色欧美亚洲狠狠色五 | 国产精品天堂 | 97久久精品午夜一区二区 | 欧美日韩精品综合 | 99精品在线免费 | 亚洲人天堂 | 国产精品久久婷婷六月丁香 | 久久久久国产精品人 | 午夜网站入口 | 欧美永久精品 | 精品国产91亚洲一区二区三区www | 久久激情五月丁香伊人 | 欧美亚洲韩国国产综合五月天 | 天天天天操 | 一区二区三区免费看 | 精品视频手机在线观看免费 | 91小视频在线观看免费版高清 | 精品96久久久久久中文字幕无 | 色噜噜亚洲男人的天堂 | 夜夜操免费视频 | 亚洲午夜精品一区二区三区 | 91精品久久久久久久 | 国产亚洲欧美日韩v在线 | 免费成人午夜视频 | 蜜桃视频在线播放 | 日韩欧美一区二区视频 | 久久一区二区三区四区 | 国产精品热 | 日日夜夜免费精品视频 | 国产亚洲欧美一区 | 久草视频手机在线 | 久久久久久国产精品免费免费 | 91热视频在线观看 | 亚洲成a人在线观看 | 一本大道香蕉中文日本不卡高清二区 | 国产在线不卡午夜精品2021 | 国产精品视频在线观看 |